Infectious Diseases and Neurological Infections

At Karolinska Institutet, research in bacterial infections and nervous system diseases includes studies on brain abscess, with a focus on finding effective treatment options that may support recovery while maintaining good clinical outcomes.

  • Comparing oral and intravenous antibiotic treatment for bacterial brain abscess
  • Evaluating whether a simpler treatment approach can be as effective as standard care

This work is aimed at improving treatment convenience and effectiveness for serious intracranial infection.

Autoimmune and Connective Tissue Disease Research

Clinical research in immune system diseases and skin and connective tissue diseases includes diffuse cutaneous systemic sclerosis, where investigators are studying strategies to improve survival and reduce the risk of major organ damage in early disease.

  • Testing stem cell transplantation as an early treatment option
  • Assessing how treatment strategies may help prevent organ failure

The goal is to identify a more effective approach for a severe autoimmune condition that can affect multiple organs.

Dermatology and Rare Genetic Skin Disorders

Work in skin and connective tissue diseases at this site also covers Netherton syndrome, a rare inherited disorder, with trials designed to assess whether a new topical therapy can safely control symptoms and improve patient well-being.

  • Studying a topical treatment for clinical safety and effectiveness
  • Exploring symptom control in a rare skin disease

This research supports the development of better options for people living with a difficult-to-manage dermatologic condition.

Hematology and Cancer Therapeutics

Clinical trials in hemic and lymphatic diseases focus on hematological malignancies, including leukemia and lymphoma, with research aimed at testing the safety and potential benefit of new cancer treatments for patients with advanced or relapsed disease.

  • Evaluating a new therapy for blood cancers such as AML, ALL, DLBCL, and multiple myeloma
  • Assessing treatment safety and tolerability in difficult-to-treat malignancies

These studies reflect an effort to expand options for patients with aggressive cancers who have limited standard treatments.